Features of the new Macroduct Advanced include a touch screen user interface with built-in step-by-step graphical instructions that further standardize pilocarpine iontophoresis and sweat collection for optimum results.
In addition, the revised shape of electrodes and Macroduct collector offer greater convenience when working with neonates and toddlers with small limbs.
This system truly is meant to enhance laboratory workflow in meeting protocols and traceability requirements with flexible options for data management.
ELITechGroup Biomedical Systems is in the laboratory diagnosis of cystic fibrosis with the proven products for sweat stimulation, collection, and analysis.
The company is also a key player in supporting global laboratories with the world's most advanced cytocentrifuge rotor, slide stainers, and osmometers.
cystetic Medicines doses first healthy volunteer in CM001 Phase one clinical trial
First Patient Enrolled in Phase 3 Clinical Trial Evaluating ARINA-1 in Lung Transplant
Insmed completes adult patient enrolment in brensocatib pivotal ASPEN study
Aluna Raises USD 15.3m in Series B Funding
CF Foundation Invests Up to USD 15m in ReCode Therapeutics for Development of mRNA Therapy
Markels Named to Arcturus Therapeutics Board of Directors
SpliSense commences first-in-human, Phase 1/2 clinical trial of SPL84 to treat cystic fibrosis
Arcturus Forges Collaboration with CSL to Develop and Commercialize Self-amplifying mRNA Vaccines
Vanda Pharmaceuticals VPO-227 granted US FDA Orphan Drug Designation for the treatment of cholera